Name
antihypertensive_n
Label
Number of anti-hypertensives?
Units
medications
Type
numeric
Visit vs Number of anti-hypertensives?
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline | 318 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 318 |
| Final | 300 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | 1 | 301 |
Treatment Arm vs Number of anti-hypertensives?
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 318 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 318 |
| HLSE | 106 | 2.3 | ± 1.3 | 2.0 | 0.0 | 7.0 | - | 106 |
| HLSE-O | 106 | 2.5 | ± 1.3 | 2.0 | 0.0 | 6.0 | - | 106 |
| HLSE-P | 106 | 2.3 | ± 1.5 | 2.0 | 0.0 | 6.0 | - | 106 |
Treatment Arm vs Number of anti-hypertensives?
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 300 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | - | 300 |
| HLSE | 100 | 2.3 | ± 1.2 | 2.0 | 0.0 | 5.0 | - | 100 |
| HLSE-O | 101 | 2.5 | ± 1.4 | 2.0 | 0.0 | 6.0 | - | 101 |
| HLSE-P | 99 | 2.3 | ± 1.6 | 2.0 | 0.0 | 6.0 | - | 99 |
Age vs Number of anti-hypertensives?
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 318 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 318 |
| 45-54 years | 53 | 2.0 | ± 1.2 | 2.0 | 0.0 | 5.0 | - | 53 |
| 55-64 years | 139 | 2.5 | ± 1.5 | 2.0 | 0.0 | 7.0 | - | 139 |
| 65-74 years | 121 | 2.4 | ± 1.3 | 2.0 | 0.0 | 6.0 | - | 121 |
| 75 or older | 5 | 2.6 | ± 1.3 | 2.0 | 1.0 | 4.0 | - | 5 |
Age vs Number of anti-hypertensives?
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 300 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | - | 300 |
| 45-54 years | 49 | 2.0 | ± 1.2 | 2.0 | 0.0 | 5.0 | - | 49 |
| 55-64 years | 127 | 2.4 | ± 1.5 | 2.0 | 0.0 | 6.0 | - | 127 |
| 65-74 years | 119 | 2.4 | ± 1.3 | 2.0 | 0.0 | 6.0 | - | 119 |
| 75 or older | 5 | 3.0 | ± 1.6 | 3.0 | 1.0 | 5.0 | - | 5 |
Gender vs Number of anti-hypertensives?
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 318 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 318 |
| Male | 234 | 2.5 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 234 |
| Female | 84 | 2.0 | ± 1.2 | 2.0 | 0.0 | 5.0 | - | 84 |
Gender vs Number of anti-hypertensives?
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 300 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | 1 | 301 |
| Male | 221 | 2.5 | ± 1.4 | 2.0 | 0.0 | 6.0 | 1 | 222 |
| Female | 79 | 2.0 | ± 1.3 | 2.0 | 0.0 | 5.0 | - | 79 |
Race vs Number of anti-hypertensives?
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 318 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 318 |
| African American or Black | 42 | 2.7 | ± 1.4 | 2.5 | 0.0 | 6.0 | - | 42 |
| Caucasian | 252 | 2.3 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 252 |
| Other | 24 | 2.0 | ± 1.3 | 2.0 | 0.0 | 4.0 | - | 24 |
Race vs Number of anti-hypertensives?
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 300 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | - | 300 |
| African American or Black | 40 | 2.7 | ± 1.4 | 3.0 | 0.0 | 5.0 | - | 40 |
| Caucasian | 237 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | - | 237 |
| Other | 23 | 2.1 | ± 1.3 | 2.0 | 0.0 | 5.0 | - | 23 |